SNGXSOLIGENIX, INC.同业对比
SOLIGENIX, INC. 与SIC 2834 行业的逐项对比:市值、估值、增长、盈利能力、质量与总回报,以及在同业组内的排名。所有数值均由引擎从 SEC 申报与延迟行情计算,排名仅为组内排序位置 —— 描述性数据,非投资建议。
完整同业对比
同业组:同 SIC 行业分类 | 公司 | 市值 | 市盈率(TTM) | 市净率 | 市销率 | 营收同比增长 | 净利同比增长 | 息税前利润率 | 净资产收益率 | 投入资本回报率 | 皮氏 F 值 | 一年总回报 | 股息率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SNGX本股 | $6M#9 | — | 1.8x#8 | 46.2x#4 | -85.8%#5 | -33.7%#12 | -9923.2%#4 | -359.2%#10 | — | 4#1 | -87.2%#1 | — |
| DRMA | $5M#10 | — | 0.7x#5 | — | — | 38.5%#7 | — | -117.9%#6 | — | — | — | — |
| CNSP | $8M#5 | — | 119.9x#12 | — | — | -6.7%#11 | — | -22417.9%#13 | — | — | — | — |
| ADIL | $7M#6 | — | 1.9x#9 | — | — | 39.6%#6 | — | -214.6%#8 | — | — | — | — |
| TRAW | $7M#7 | — | 0.6x#3 | 2.5x#2 | 1134.5%#1 | 105.5%#2 | -640.7%#2 | 79.2%#2 | — | — | — | — |
| RVPH | $5M#11 | — | 0.3x#1 | — | — | 33.6%#9 | — | -113.9%#5 | — | — | — | — |
| TCRT | $45M#2 | — | 34.9x#11 | 8987.3x#6 | -50.0%#3 | 10.8%#10 | -84500.0%#6 | -324.2%#9 | — | — | — | — |
| ACXP | $6M#8 | — | 0.9x#6 | — | — | 43.5%#4 | — | -113.6%#4 | — | — | — | — |
| REVB | $4M#12 | — | 0.3x#2 | — | — | 40.7%#5 | — | -68.6%#3 | — | — | — | — |
| HEPA | $9M#3 | 0.3x#3 | 5.0x#10 | — | — | 37.3%#8 | — | -445.8%#11 | — | — | — | — |
| INDP | $173M#1 | — | 138.8x#13 | — | — | -38.8%#13 | — | -1670.8%#12 | — | — | — | — |
| JUNS | $3M#13 | — | — | 143.2x#5 | — | -254.4%#14 | -40873.2%#5 | — | — | — | — | — |
| ONCO | $9M#4 | 0.0x#1 | 0.7x#4 | 10.6x#3 | -67.7%#4 | 76.1%#3 | -2190.0%#3 | -119.5%#7 | — | — | -99.6%#2 | — |
| PTPI | $3M#14 | 0.0x#2 | 1.5x#7 | 0.5x#1 | -12.2%#2 | 113.4%#1 | -90.8%#1 | 108.0%#1 | — | — | — | — |
数值来自 SEC 申报与延迟行情;排名仅为该组内的排序位置 —— 描述性数据,不构成评级或建议。 本表构建超时,仅覆盖该组的一部分成员;排名仅相对于已列出的行,稍后会自动补全。 数据构建于 2026-08-01。
数据来自 SEC XBRL 申报与延迟行情 · 排名为组内排序 · 仅供参考 · 非投资建议